This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • A Study of Mirvetuximab Soravtansine vs. Investiga...
Clinical trial

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (MIRASOL)

Read time: 1 mins
Last updated:7th Feb 2021
Status: Recruiting
Identifier: NCT04209855
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest